DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/wv8g4z/parkinsons) has announced the addition of the "Parkinson's Disease Global Clinical Trials Review, H2, 2013" report to their offering.
Parkinson's Disease Global Clinical Trials Review, H2, 2013 provides data on the Parkinson's Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Parkinson's Disease. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Parkinson's Disease.
Top Companies Participating in Parkinson's Disease Therapeutics Clinical Trials
- C. H. Boehringer Sohn AG & Co. KG
- UCB S.A.
- Novartis AG
- Teva Pharmaceutical Industries Limited
- AbbVie Inc.
- GlaxoSmithKline plc
- H. Lundbeck A/S
- Kirin Holdings Company, Limited
- Eisai Co., Ltd.
- Bial - Portela & Ca, S.A.
For more information visit http://www.researchandmarkets.com/research/wv8g4z/parkinsons